FDA halts use of 2 treatments found to be ineffective against omicron
WASHINGTON — U.S. regulators restricted the use of a pair of COVID-19 monoclonal antibody therapies after scientific evidence suggested they are unlikely to be effective against the omicron variant.
Tribune News Service ·